Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 1;59(3):230-242.
doi: 10.1097/RLI.0000000000001010.

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction

Affiliations
Review

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction

Roberto Lo Gullo et al. Invest Radiol. .

Abstract

Primary systemic therapy (PST) is the treatment of choice in patients with locally advanced breast cancer and is nowadays also often used in patients with early-stage breast cancer. Although imaging remains pivotal to assess response to PST accurately, the use of imaging to predict response to PST has the potential to not only better prognostication but also allow the de-escalation or omission of potentially toxic treatment with undesirable adverse effects, the accelerated implementation of new targeted therapies, and the mitigation of surgical delays in selected patients. In response to the limited ability of radiologists to predict response to PST via qualitative, subjective assessments of tumors on magnetic resonance imaging (MRI), artificial intelligence-enhanced MRI with classical machine learning, and in more recent times, deep learning, have been used with promising results to predict response, both before the start of PST and in the early stages of treatment. This review provides an overview of the current applications of artificial intelligence to MRI in assessing and predicting response to PST, and discusses the challenges and limitations of their clinical implementation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: K.P. received payment for activities not related to the present article including lectures including service on speakers bureaus and for travel/accommodations/meeting expenses unrelated to activities listed from the European Society of Breast Imaging, IDKD 2019, Bayer, Siemens Healthineers, and Olea Medical, and is a consultant for Merantix Healthcare and AURA Health Technologies GmbH. J.T. received payment for activities not related to the present article including lectures and travel/accommodation/meeting expenses. The rest of the authors declare no potential competing interests. The project was supported by the NIH/NCI Cancer Center Support Grant (P30 CA008748). E.M. and J.T. were funded by an institutional grant provided by the Netherlands Cancer Institute. The funding sources were not involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. J.H. was supported by the Breast Cancer Research Foundation.

Figures

FIGURE 1
FIGURE 1
Schematic description of workflow of artificial intelligence–enhanced imaging biomarker development using machine learning and deep learning approaches. For deep learning, the image segmentation step is not necessarily required.
FIGURE 2
FIGURE 2
Receiver operation characteristic (ROC) curves of the multiparametric magnetic resonance imaging model using the XGBoost classifier with 4-fold cross-validations for predicting of (A) RCB class and (B) RFS, and 3-fold cross-validation in prediction of (C) DSS. The solid orange lines represent the average ROC curves, the lighter lines depict the ROC curve for each fold, and the gray-shaded areas indicate the confidence interval for the predictions using multiparametric magnetic resonance imaging model. Reprinted with permission from Tahmassebi et al.
FIGURE 3
FIGURE 3
Schematic of the proposed transfer learning method encompassing 5 steps: (1) feature extraction, (2) dynamic feature selection, (3) optimal feature selection, (4) classification on the fine-tuning data set, (5) classification on the independent test. Reprinted under a Creative Commons (CC BY 4.0) license from Comes et al.
FIGURE 4
FIGURE 4
Flowchart illustrating the radiomics workflow and the application of the RQS. The workflow encompasses the essential steps in radiomic analysis. The RQS both rewards and penalizes a study's methodology and analyses, thus promoting best scientific practice. RQS, radiomics quality score; VOI, volume of interest. Reprinted with permission from Lambin et al.

References

    1. Cardoso F Kyriakides S Ohno S, et al. . Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30:1194–1220. - PubMed
    1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) . Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19:27–39. - PMC - PubMed
    1. Fisher B Bryant J Wolmark N, et al. . Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672–2685. - PubMed
    1. King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015;12:335–343. - PubMed
    1. Mamtani A Barrio AV King TA, et al. . How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23:3467–3474. - PMC - PubMed